4//SEC Filing
Sunshine Biopharma, Inc 4
Accession 0001128732-16-000030
$SBFMCIK 0001402328operating
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 11:41 AM ET
Size
5.2 KB
Accession
0001128732-16-000030
Insider Transaction Report
Form 4
Slilaty Steve N.
DirectorCEO and President10% Owner
Transactions
- Other
Common Stock
2016-10-10−136,861,968→ 215,014,224 total(indirect: Owned by Advanomics Corporation, an entity controlled by Reporting Person.)
Footnotes (1)
- [F1]136,861,968 shares owned by Advanomics Corporation, an entity controlled by Reporting Person, were disposed of pursuant to a share exchange with an unrelated party; no consideration was received as a result of the share exchange.
Documents
Issuer
Sunshine Biopharma, Inc
CIK 0001402328
Entity typeoperating
IncorporatedCO
Related Parties
1- filerCIK 0001402328
Filing Metadata
- Form type
- 4
- Filed
- Nov 6, 7:00 PM ET
- Accepted
- Nov 7, 11:41 AM ET
- Size
- 5.2 KB